| Hypoxia--a key regulatory factor in tumour growth | Nature Reviews Cancer | 2002 | 4K |
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 2.8K |
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study | Proceedings of the National Academy of Sciences of the United States of America | 2003 | 1.6K |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Journal of the National Cancer Institute | 2006 | 1.5K |
| Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse | Journal of Clinical Oncology | 2006 | 841 |
| Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial | Journal of Clinical Oncology | 2001 | 824 |
| ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response | Molecular Cell | 2017 | 800 |
| Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma | Molecular and Cellular Biology | 2005 | 754 |
| Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer | Lancet, The | 1992 | 724 |
| hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer | Clinical Cancer Research | 2008 | 555 |
| Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization | Nature Medicine | 2011 | 486 |
| Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress | Cancer Cell | 2015 | 421 |
| HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron | Cancer Cell | 2002 | 410 |
| Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours | European Journal of Cancer | 2002 | 397 |
| Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival | British Journal of Cancer | 2001 | 390 |
| Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters | Current Biology | 2000 | 372 |
| Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis | Journal of Pathology | 1995 | 369 |
| Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma | Journal of Clinical Oncology | 2001 | 367 |
| Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma | Cancer Research | 2006 | 353 |
| Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast | British Journal of Cancer | 1999 | 351 |
| New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes | Blood | 2010 | 305 |
| Macrophage responses to hypoxia: relevance to disease mechanisms | Journal of Leukocyte Biology | 1999 | 298 |
| Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function | Cancer Research | 2005 | 288 |
| Tumor-associated macrophages in breast cancer | Journal of Mammary Gland Biology and Neoplasia | 2002 | 286 |
